Orally bioavailable small molecule CD73 inhibitors reverse immunosuppression by blocking adenosine productionInternal research program led to discovery of clinical candidate […]
IRVINE, Calif., April 27, 2020 (GLOBE NEWSWIRE) — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for […]